CCR7 and pancreatic neoplasm: CCR7 expression is significantly increased in patients with pancreatic cancer and induces intra-tumor angiogenesis and lymphangiogenesis through chemotactic interactions with its ligand, CCL21 (Zhao et al., 2011).